Top-News

Bio-Techne Aktie News

Aktie
WKN:  A12ENG ISIN:  US09073M1045 US-Symbol:  TECH Branche:  Biotechnologie Land:  USA
61,69 $
-1,85 $
-2,91%
52,981 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
8,01 Mrd. €
Streubesitz
-
KGV
109,47
Dividende
0,080 $
Dividendenrendite
0,13%
neu: Nachhaltigkeits-Score
46 %
Index-Zuordnung
S&P 500

Bio-Techne News

25.11.25 - PR Newswire
Bio-Techne to Present at Upcoming Investor Conferences
Bio-​Techne to Present at Upcoming Investor Conferences PR Newswire
18.11.25 - PR Newswire
Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio
Bio-​Techne Licenses AI-​Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio PR Newswire
06.11.25 - PR Newswire
Bio-Techne to Present at Upcoming Investor Conferences
Bio-​Techne to Present at Upcoming Investor Conferences PR Newswire
05.11.25 - PR Newswire
BIO-TECHNE DECLARES DIVIDEND
BIO-​TECHNE DECLARES DIVIDEND PR Newswire
05.11.25 - PR Newswire
Bio-Techne Releases First Quarter Fiscal 2026 Results
Bio-​Techne Releases First Quarter Fiscal 2026 Results PR Newswire
04.11.25 - PR Newswire
AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients
AI-​Powered Spatial Biology Workflow from Bio-​Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients PR Newswire
03.11.25 - PR Newswire
ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics
ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics PR Newswire
28.10.25 - PR Newswire
Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
Bio-​Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-​Protein Interactions Research PR Newswire
23.10.25 - PR Newswire
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital PR Newswire
15.10.25 - PR Newswire
Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results
Bio-​Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results PR Newswire
09.10.25 - PR Newswire
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
Bio-​Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032 PR Newswire
26.09.25 - PR Newswire
Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications
Bio-​Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications PR Newswire
24.09.25 - PR Newswire
Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report
Bio-​Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report PR Newswire
09.09.25 - PR Newswire
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California PR Newswire
27.08.25 - PR Newswire
Bio-Techne to Present at Upcoming Investor Conferences
Bio-​Techne to Present at Upcoming Investor Conferences PR Newswire
14.08.25 - PR Newswire
ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory
ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory PR Newswire
06.08.25 - PR Newswire
Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
Bio-​Techne Releases Fourth Quarter Fiscal 2025 Results PR Newswire
06.08.25 - PR Newswire
BIO-TECHNE DECLARES DIVIDEND
BIO-​TECHNE DECLARES DIVIDEND PR Newswire
05.08.25 - PR Newswire
Bio-Techne Announces Exosome Diagnostics Divestiture
Bio-​Techne Announces Exosome Diagnostics Divestiture PR Newswire
05.08.25 - PR Newswire
ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine
ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine PR Newswire

Newssuche

Videos

newspaper
05.12.25 +1,73%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »